Varian Medical Systems (VAR) Gets a Buy Rating from Barrington


In a report released today, Michael Petusky from Barrington maintained a Buy rating on Varian Medical Systems (NYSE: VAR), with a price target of $129. The company’s shares closed yesterday at $109.21.

Petusky wrote:

“We recently spent two days with senior executives from Varian Medical as they met with Barrington accounts in Madison, Milwaukee and Chicago. Below is a brief overview.”

According to TipRanks.com, Petusky is a 4-star analyst with an average return of 16.7% and a 63.5% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics Inc, Merit Medical Systems, and DENTSPLY SIRONA Inc.

Varian Medical Systems has an analyst consensus of Hold, with a price target consensus of $123.25.

See today’s analyst top recommended stocks >>

The company has a one-year high of $130.29 and a one-year low of $98.34. Currently, Varian Medical Systems has an average volume of 569.3K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Varian Particle Therapy segments.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts